Lindsay Rosenwald Taken A Step Ahead In Field Of LifeScience & HealthCare Investment

OpusPoint Partners:

Investing in the Future ofHealthcare and Life Sciences

At OpusPoint Partners,we have a vision for an amazing future for the life science and healthcare industry. We believe in that vision so strongly that we are investingmoney and time to advance life sciences and biotechnology. We also believe in a strong, healthy future for human kind. With proper funding and research, we know that the quality of healthcare can be catapulted to a new and more effective level.

A Vision for the Future of Healthcare

With this vision in mind, Michael S. Weiss and Dr. LindsayRosenwald created OpusPoint Partners in 2009. These men have over 40 years of combined experience in the fields of healthcare, life sciences and biotechnology investing. Both are creative thinkers who have founded a number of biotech companies over the years.

Dr. Lindsay A. Rosenwaldhas most recently founded Cougar Biotechnology Inc.,which is a Los Angeles-based firm that focuses on the field of oncology. Cougar’s oncology portfolio includes some promising experimental drugs effective in treatingnumerousforms of cancer. One of those in particular has drawn the interests of researchers and investors. It has proven to work well at treating late-stage prostate cancer. Dr. Lindsay Rosenwald negotiated a deal with Johnson & Johnson for Cougar Biotech Labs at a price of approximately one billion dollars in July of 2009.

Achieving the Objectives

The objective of Lindsay Rosenwald and OpusPoint Partners is twofold: to move forward withintegrity in achieving long-term goals and short-termgains, and to build solid relationships in both the world of investing and biotechnology.  By establishing strong relationships withother industry leaders who share similar values, they believe that these goals and objectives can be obtained without the sacrifice of their principles and standards.

For OpusPoint Partners, honest investing with full and open disclosure is more than just good business. This is a way of life.They currently work with a wide range of corporations to create a team approach to supporting emerging new businesses in an effort to reach critical goals.  Dr. Lindsay Rosenwald and OpusPoint Partners have made a genuine commitment to discover and invest in innovative technologies in the fields of life sciences and healthcare.These pioneers of research and investment believe in a better future for us all; a future where diseases are diagnosed and treated by more effective methods.

At OpusPoint Partners, Dr. Lindsay Rosenwald, his business partners and colleagues, believe in a world where people’s lives and health are greatly improved. They believe in creating a future where mankind achieves a much stronger quality of life. Through thisunique vision they are making a true difference in theirworld. In order to attain this dream of a better tomorrow for us all, their journey often involves providing advisory services to start-up businesses.  Sometimes it requires investing in publicly-traded companies.

Raising the Bar

Dr. Lindsay Rosenwald and OpusPoint Partners, is working to raise the bar for investors. Their efforts include advising emerging biotechnical research facilities. They believe that a strong moral compass along with sound business principles can significantly minimize risks and thereby maximize returns for investors and so far, this unique formula is proving to be successful.

For the past 17 years, Dr. Rosenwald has been a well-respected Wall Street biotechnology entrepreneur. His business ethics have not gone unnoticed. He has, in fact, been instrumental in the founding and re-capitalization of dozens of private and public biotechnology and life-sciences companies. He earned his M.D. from the Temple University School of Medicine and his B.S. in Finance from Pennsylvania State University.

An Innovative Business Philosophy

During his impressive twenty-year career, Dr. Lindsay Rosenwald has founded over fifty companies and managed the Aries Funds from 1994 through 2007 with peak assets under his management in 2000 of over $1BB dedicated to healthcare investments. During the years of 2002 through 2006, he also managed the Orion Fund, which was a committed capital fund dedicated to private investments in biotechnology, in particular PIPEs.

The philosophy behind OpusPoint Partners will be to build a successful life science and healthcare network that plays fair and does not take short cuts to reach its goals. Dr. Rosenwald and his associates know that the world we currently live in often provides too many opportunities for business leaders to use less than ethical tactics to try to manipulate outcomes of clinical trials and hence increase quarterly earnings.

OpusPoint Partners is a uniqueenterprise that continually reinforces its commitment to its employees and investors. Their promise is to deal fairly in all aspects of experimental drug trials. In the investigation and manufacture of experimental drugs, they are resolute about these vows.

The Benefits of Making the World a Better Place

The future of OpusPoint Partners remains highly promising with Michael S. Weiss and Dr. Lindsay Rosenwald as its founders. They are utilizing their expertise in the fields of medicine and investments to effect some very real changes in the way diseases are diagnosed. They believe that the treatment of patients can be transformed.

But revolutionizing these age-old medicaland healthcare techniques and procedures is no small task, nor is it for the faint of heart. In order to effect changes on such a grand scale requires commitment; it requires time and money.  It also involves a strong resolve to work hard within the ethical boundaries that other drug research companies may have discarded in favor of better profits.

Dr. Rosenwaldunderscoresthe fact that over the past few years, projected goals have already been surpassed. By applying best practices and processes, OpusPoint Partners moves ahead earning superior, risk-adjusted returns and helpingto finance and support more than 20 companies in the past two years alone.  This achievement is marked by a continuing commitment to the financial world and the world of drug research.

Credentials and Lifetime Achievements

Dr. LindsayRosenwald is currently a member of the Board of Directors at the Republican Jewish Coalition. He is one of the most broadly-informed and well-connected individuals in the biotechnology finance sector.The future of OpusPoint Partners looks very promising with Dr. Rosenwald as its vanguard.

Lindsay Rosenwald Investing in the Future ofLife Sciences and Healthcare

OpusPoint Partners is an innovative new company with a unique vision for the future of the life science and healthcare industry. That vision includes some cutting edge technologies but also some forward thinking business philosophies.

As with alllofty visionssuchas this, itwill take immense commitment from quality entrepreneurs to accomplish. Michael S. Weiss and Dr. Lindsay Rosenwald created OpusPoint Partners in 2009 with the idea of combining their 40 years of experience and business acumen working toward revolutionizing the fields of healthcare, life sciences and biotechnology investing. Both these men are well equipped to do this job and have already founded a number of biotech companies over the years.

With so much at stake, OpusPoint Partners along with Dr. Lindsay Rosenwald, is working toward making those leaps to advance and even transform the world of life sciences and biotechnology investing. Rosenwald, along with his team at OpusPoint, believe in a future where mankind significantly improves the quality of healthcare, as well as healthcare investing.

Advancements in the Future of Healthcare
Recently, Dr. Lindsay A. Rosenwaldfounded Cougar Biotechnology Inc. This Los Angeles-based company focuses on the field of oncology. Their oncology portfolio includes some very promising experimental drugs, which are proving to be effective in treatingnumerousforms of cancer.

One in particular has caused some excitement and drawn the interests of researchers and investors. It is a new drug that has been proven to work well at treating late-stage prostate cancer. In July of 2009, Dr. Lindsay Rosenwaldwas able to negotiate a deal with Johnson & Johnson for Cougar Biotech Labs at a price of approximately one billion dollars.

Realizing the Objectives
Lindsay Rosenwald and OpusPoint Partners believe they can continue to move forward with projects like these that alter healthcare significantly and produce results for the greater good of mankind. They achieve these goals with integrity, building solid relationships in both the world of investing and biotechnology.

Establishing robust relationships withother industry leaders who share similar values is a hallmark of the business strategy of both Dr. Lindsay Rosenwald and OpusPoint Partners. They believe in reaching goals and objectives through honesty, integrity and hard work. Their success has proven that you can obtain these objectives without the sacrifice ofprinciples and standards. Honest investing with full and open disclosure is more than just good business for OpusPoint Partners. This is the ideology they live by.

Creating New Partnerships for a Better Tomorrow
Dr. Lindsay Rosenwald and OpusPoint Partners currently work with a wide range of businesses and organizations to create a team approach for thesupport of emerging new businesses. They are making great strides toward building a powerful network of like-minded individuals who all possess a genuine commitment to discover and invest in innovative technologies in the fields of life sciences and healthcare.

With pioneers such as these in the areas of research and investment, you can be sure that thefuture of healthcare and life sciences will continue to flourish. These days, the medical field is well-aware of its need for diseases of all types to be diagnosed and treated by more effective methods. At OpusPoint Partners, Dr. Lindsay Rosenwald, his business partners and colleagues, know that the dream can become a reality with hard work and dedication.

The dream of a better tomorrow continues to be the fuel that fires this vision of a much stronger quality of life for us all. And thisunique vision of making a true difference in the world has become a driving force for Dr. Lindsay Rosenwald and OpusPoint Partners. History shows that dreams like this always take time, money and hard work, plus dedication from those involved.

Raising the Bar for Investors
Over the course of this journey, Dr. Lindsay Rosenwald and OpusPoint Partners must oftenprovide advisory services to start-up businesses. At times they also must invest in publicly-traded companies in order to move the vision forward.

One of their key objectives is to raise the bar for all investors. Whether working in the advisory capacity with emerging biotechnical research facilities or actually investing, OpusPoint followsa strong moral compass.With sound business principleslike these, the risks can be significantly minimizedand the returns for investors maximized. This uniqueformula has proven successful beyond anyone’s wildest dreams.

Utilizing Ethical Business Practices
The philosophy behind OpusPoint Partners is to build a positive and effective life science and healthcare network that plays fair and won’t take short cuts to reach its goals. Dr. Rosenwaldknows from experience, that today’s world often provides many opportunities for business leaders to use less than ethical tactics to try and manipulate outcomes of clinical trials with an eye toward greaterquarterly earnings. Does the end justify the means?

At OpusPoint Partners, the answer is a resounding no! This unique enterprise continually reinforces its commitment to its employees and investors to conduct business with higher standards than many of days gone by. In the investigation and manufacture of experimental drugs, they are resolute about this commitment to honest, above-board business dealings.

A Long and Fruitful Career
The future of OpusPoint Partners remains highly promising with Michael S. Weiss and Dr. Lindsay Rosenwald as its founders. They are utilizing their expertise in the fields of medicine and investments to effect some very real changes in the way diseases are diagnosed. They believe that the treatment of patients can be transformed.

Dr. Rosenwald, a well-respected Wall Street biotechnology entrepreneur, has worked for the past 17 years utilizing strong business ethics in the founding and re-capitalization of dozens of private and public biotechnology and life-sciences companies. He earned his M.D. from the Temple University School of Medicine and his B.S. in Finance from Pennsylvania State University.

Throughout an impressive twenty-year career, Dr. Lindsay Rosenwald has established over fifty companies. He also managed the Aries Funds from 1994 through 2007 with peak assets under his management in 2000 of over $1BB dedicated to healthcare investments. From 2002 to 2006, hemanaged the Orion Fund, which was a committed capital fund dedicated to private investments in biotechnology, in particular PIPEs.

Dr. Lindsay Rosenwald is currently a member of the Board of Directors at the Republican Jewish Coalition. He is one of the most broadly-informed and well-connected individuals in the biotechnology finance sector. The future ofOpusPoint Partners indeed looks promising with Dr. Rosenwald at its helm.

Dr. Lindsay Rosenwald – A Hisrtorical Figure For Biotechnology

Dr. Lindsay Rosenwald is the founder and the current director of the Paramount, as well as other companies that he has established and supported.

He graduated from the Abington High School, then in 1973, he pursued and continued his studies at Pennsylvania State University and became a member of the the business honors society of the school. He finished Bachelor and graduated his Degree in Finance in 1977. He had been dreaming to become a successful businessman and a doctor at the same time, which in the later years, came true.

He took medicine course at the Temple university right after he graduated from Pennsylvania . He practiced medicine for two and a half years. he then,thought and made a decision to pursue other studies, business. in the year 1986, he headed to Wall Street where he became an analyst and physician while making some investment grow. Lindsay Rosenwald also practiced business managing as the Managing Director of Finance at the DH Blair and Co an exclusive firm for investment and finance, but it did not take years of him to stay.

He supported a lot of pharmaceutical companies to become established and well known in the same field. He is someone that you may remember even after a century due to his brilliant works. Paramount Group of Companies had been growing until now. It has succeeded and introduced new companies like Paramount Capital Asset who are responsible for the researches; Paramount Capital Investment Who is responsible for financing other new companies who needs help in terms of financial matters; Paramount BioSciences which is related to producing and improving new science related to Biotechnologies. All of these and more had make Dr Lindsay Rosenwald famous and great. Paramount Group of Companies have been supporting in different kinds, ranging from banking and direct investment, asset management are just some of the branches who had support starting from the beginning till they succeed.

To name a few companies that he is associated with are the polarx, who developed a treatment for acute leukemia, the Trisenox; Titan Pharmaceuticals who produced the treatment for schizophrenia; Sypress Bioscience who introduced Prosorba Column, a treatment for rheumatoid arthritis, and Savella which can cure fibromyalgia. Another company that you may associate his name, is the Biocryst which made a treatment for ifluenza like H1N1, they have made the Peramivir.

Dr Lindsay Rosenwald famous is still known today by many people especially in biotechnology field. He is a successful person who has made things possible in terms of life science and medicine. He is the person behind the success of most pharmaceutical companies, a historical figure for biotechnology, and an inspiration to everybody.

Lindsay Rosenwald Promoting Biotechnology

Dr. Lindsay Rosenwald has a nearly twenty year span of promoting the biotechnical field  in research and product creation. As one of the foremost entrepreneurs in biotechnology, he has founded over forty companies and given liberally to educational and research institutions in the biomtechnical and pharmaceutical fields. Dr. Rosenwald’s companies also provide financial backing for a number of companies working in the area of biotechnology.

For his financial work, Dr. Rosenwald is known as a venture capitalist, hedge fund manager and an investment banker. Dr. Lindsay Rosenwald uses his first company established, Paramount Biocapital, to finance other companies that he sees potential in. It is in these ventures that many important advancements in disease treatment are made possible.

Lindsay Rosenwald graduated Abington High School in Pennsylvania in 1973 and went on to study at Pennsylvania State University graduating there in 1977 with a Bachelors of science in finance. He was a member of the prestigious Beta Gamma Sigma, a business school honor society, while attending Pennsylvania State. Next, Lindsay attended Temple University for his medical degree which he earned in 1983.

Afyter his education, Lindsay, now entitled Dr. Rosenwald, began his career in medicine with an internship at Abington Hospital in Pennsylvania. This was in 1984, after finishing that, Dr. Rosenwald went into private practice until 1986.He then made the move to Wall Street to become an analyst and physician, a rare career move in those days.

The Paramount Group was formed by Dr. Rosenwald in 1991, and later in the same year he formed Paramount Biocapital Inc. , which had a goal to assist smaller companies in the biotechnology field with start-up funds as well as funds for growth and research. By 1994, Dr.Lindsay Rosenwald had become the chairman of the Paramount Group then Biocapital began banking services for the life sciences industry companies.

The Paramount Group has enjoyed renown growth and has added large companies such as Paramount Biosciences and Paramount Corporate Development. These companies are specialized in investments and developments within the Paramount Group’s companies.

Many of the companies founded by Dr. Rosenwald are known for their important breakthroughs in biotechnology. One such breakthrough was the founding of the first company to be publicly traded that specialized in genetic therapies and cancer vaccines. Other real achievements were fastest FDA approval time for a medicine in the United States at one of his companies for a leukemia drug know as Arsenic Trioxide, it passed approval in under thirty months. Cougar Biotechnology, the first company to be sold even though they had only one drug which had not even been FDA approved yet, was bought by Johnson and Johnson in 2009 for one billion dollars because of its drug to treat prostate cancer.

Lindsay Rosenwald- Founder of Paramount Capital Asset Management

Lindsay Rosenwald is a great leader in the biotechnology industry. His contributions to the research and development of Biotechnology have been humongous. Lindsay has got almost two decades or experience advanced research on clinical and drug development. With such a great experience, he founded numerous of companies in the biotechnology field to contribute the drug development and the clinical research. Almost all his companies directly or indirectly associated and helped growing the biotechnology industry in the market. In addition to this, he is also known as the venture capitalist and the hedge fund manager at Wall Street, New York. After shifting to the New York in early 1990s, he started focusing on the drug development and clinical research and founded numerous of companies.

Lindsay Rosenwald is the founder and chairman of the Rosenwald Foundation, which is a famous charitable trust that helps companies in the advanced research on biotechnology. Apart from this he is also founder of the Paramount Group Companies that include Paramount Capital Asset Management, Paramount Capital, Inc., and Paramount Capital Investment, LLC. He is the member of the advisory board of the Columbia-Presbyterian Health Sciences and Advisory Counsel, which regularly meets twice a year to felicitate the people who have contributed for the biotechnology filed. This is a great honor for the people in the research and development of Biotechnology.

Lindsay Rosenwald is the director many number of private limited and public limited companies around the world. His companies are known for getting the fast approvals from the FDA to market the drugs. One of the rare drugs for the Leukemia has got the FDA approval to market with just 30 months of clinical trials. This is the industry record in the biotechnology field as most of the drugs drug takes years together to get the market approval from the FDA.

He is the director and founder of numerous of companies such as Biocryst Pharmaceuticals, Titan Pharmaceuticals, Cypress Biosciences, Keryx Biopharmaceuticals, Javelin Pharmaceuticals, Polarx; and Enzymed Corp. He is one of the prolific leaders in the biotechnology market with wide range of experience in starting the companies. His company Cougar Biotechnology has been sold to the Johnson and Johnson for the best price of one billion dollars.

Dr. Rosenwald has received a degree in Finance in 1997 from the Pennsylvania State University and after that he received a medical degree from the Templeton University. With this experience he started his own medical practice and ran it for two years before moving to Wall Street, New York.